Founders Financial Securities’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.03M | Buy |
29,118
+10,986
| +61% | +$768K | 0.15% | 126 |
|
|
2025
Q1 | $1.27M | Buy |
18,132
+1,333
| +8% | +$93.2K | 0.11% | 186 |
|
|
2024
Q4 | $1.1M | Buy |
16,799
+2,976
| +22% | +$195K | 0.1% | 171 |
|
|
2024
Q3 | $1.08M | Buy |
13,823
+1,157
| +9% | +$90.1K | 0.1% | 175 |
|
|
2024
Q2 | $988K | Buy |
12,666
+684
| +6% | +$53.3K | 0.09% | 183 |
|
|
2024
Q1 | $812K | Buy |
11,982
+898
| +8% | +$60.8K | 0.09% | 191 |
|
|
2023
Q4 | $747K | Buy |
+11,084
| New | +$747K | 0.08% | 200 |
|